Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The developmental program of murine erythroleukemia cells.

Asterios S Tsiftsoglou1, Ioannis S Pappas, Ioannis S Vizirianakis

  • 1Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece. tsif@pharm.auth.gr

Oncology Research
|May 3, 2003
PubMed
Summary

Pharmaceutical agents can trigger differentiation and apoptosis in leukemia cells by targeting specific gene expression patterns. This research explores the mechanisms of MEL cell differentiation, offering insights into leukemia treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reshaping the Battlefield: Reprogramming the Melanoma Tumour Microenvironment (TME) by Anti-CTLA-4, Anti-PD-1, and Anti-PD-L1 Monotherapy and Combination Therapy: A Systematic Review and Meta-Analysis of Preclinical and Clinical Evidence.

Cells·2026
Same author

Imported Tungiasis in Greece: Secondary Household Transmission and Transient Mixed Liver Enzyme Elevation.

Tropical medicine and infectious disease·2026
Same author

Plant extracts and phytochemicals in canine and feline mammary cancer models: current evidence and comparative perspectives.

Veterinary research communications·2026
Same author

Fabrication and biocompatibility evaluation of 3D printed tablets using Digital Light Processing (DLP) printing for the controlled release of ketoprofen.

International journal of pharmaceutics·2026
Same author

Fabrication and Evaluation of 3D-printed Dittany-infused Patches for Anti-inflammatory Dermatological Applications.

Planta medica·2026
Same author

Noninvasive indices of hepatic steatosis and fibrosis for the prediction of obstructive coronary artery disease.

Journal of clinical lipidology·2025

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Hematopoietic stem cells (HSCs) normally differentiate into mature blood cells.
  • Leukemia involves uncontrolled proliferation of immature hematopoietic progenitors that resist differentiation and apoptosis.
  • Understanding leukemia cell differentiation mechanisms is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the mechanisms by which pharmaceutical agents induce differentiation in leukemia cells.
  • To elucidate the role of commitment to terminal maturation in MEL cell differentiation.
  • To explore the gene and protein networks involved in leukemia cell differentiation and apoptosis.

Main Methods:

  • Utilized established murine and human leukemic cell systems as models.

Related Experiment Videos

  • Examined the effects of pharmaceutical agents on leukemia cell differentiation.
  • Analyzed gene expression patterns and protein interactions during MEL cell differentiation.

    • Main Results:

    • Identified inducer-receptor-mediated processes initiating commitment to terminal maturation.
    • Observed discrete gene expression patterns leading to G1 phase growth arrest and differentiated phenotype.
    • Demonstrated differentiation-dependent apoptosis (DDA) in MEL erythroid cells.

    Conclusions:

    • MEL erythroid cell differentiation is a coordinated developmental program triggered by inducers.
    • A network of interacting genes and proteins orchestrates the lineage-restricted phenotype.
    • Targeting these differentiation pathways holds promise for leukemia treatment.